Method for classifying a cancer patient as responder or non-responder to immunotherapy

Dupont, Pierre;Gaulis, Swann;Helleputte, Thibault
(2010)

Files

No attached file found for this publication.

Details

Authors
  • Dupont, PierreUCLouvain
    Inventor
  • Gaulis, SwannGlaxoSmithKline Biologicals
    Inventor
  • Helleputte, ThibaultUCLouvain
    Inventor
Abstract
Gene expression profiles, microarrays comprising nucleic acid sequences representing gene expression profiles, and new diagnostic kits and methods are provided. The kits and methods relate to the treatment of specific populations of, for example, cancer patients, as characterised by their gene expression profile, suffering from MAGE expressing tumours. A 33 gene expression signature identifies melanoma patients responding to treatment with MAGE-A3 ASCI.
Affiliations

Citations

  • APA
  • Chicago
  • FWB

Dupont, P., Gaulis, S., & Helleputte, T. (2010). Method for classifying a cancer patient as responder or non-responder to immunotherapy (Patent No. WO/2010/029174). https://hdl.handle.net/2078.5/254490